Literature DB >> 19923032

Comorbidity in the elderly with diabetes: Identification of areas of potential treatment conflicts.

Gillian E Caughey1, Elizabeth E Roughead, Agnes I Vitry, Robyn A McDermott, Sepehr Shakib, Andrew L Gilbert.   

Abstract

AIMS: To investigate the prevalence of comorbid conditions in the elderly with diabetes and the prescribing of potentially inappropriate medicines or treatment conflicts.
METHODS: A cross-sectional study of diabetics aged >or=65 years, using prescription dispensing data from the Australian Department of Veterans' Affairs. Comorbidities were determined using the comorbidity index Rx-Risk-V. Potentially inappropriate prescribing or treatment conflicts specific for the elderly were determined from guidelines or reference compendia, in addition to the 2003 updated Beers criteria.
RESULTS: Of 18,968 diabetics, the median number of comorbidities was 5 (IQR 3-8). Diabetes and associated cardiovascular medicines accounted for 41.9% of all medicine use. Associated cardiovascular diseases were highly prevalent comorbidities. 46% had gastro-oesophageal reflux disease, 25% depression, 20% chronic airways disease or chronic pain and 15% also had heart failure or inflammation-pain. At least 16% were dispensed a medicine associated with adverse effects in patients with diabetes and 22.7% were dispensed at least one potentially inappropriate medicine.
CONCLUSION: Significant comorbid conditions in elderly diabetic patients with potential for inappropriate prescribing or treatment conflicts include arthritis, heart failure, chronic airways diseases and diseases treatable with systemic corticosteroids. Appropriate management of comorbidity should be included in guidelines for the elderly with diabetes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19923032     DOI: 10.1016/j.diabres.2009.10.019

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  60 in total

1.  Corrination of a GLP-1 Receptor Agonist for Glycemic Control without Emesis.

Authors:  Tito Borner; Jayme L Workinger; Ian C Tinsley; Samantha M Fortin; Lauren M Stein; Oleg G Chepurny; George G Holz; Aleksandra J Wierzba; Dorota Gryko; Ebba Nexø; Evan D Shaulson; Ankur Bamezai; Valentina A Rodriguez Da Silva; Bart C De Jonghe; Matthew R Hayes; Robert P Doyle
Journal:  Cell Rep       Date:  2020-06-16       Impact factor: 9.423

2.  Co-morbidity and potential treatment conflicts in elderly heart failure patients: a retrospective, cross-sectional study of administrative claims data.

Authors:  Gillian E Caughey; Elizabeth E Roughead; Sepehr Shakib; Agnes I Vitry; Andrew L Gilbert
Journal:  Drugs Aging       Date:  2011-07-01       Impact factor: 3.923

3.  Prescription medication burden in patients with newly diagnosed diabetes: a SUrveillance, PREvention, and ManagEment of Diabetes Mellitus (SUPREME-DM) study.

Authors:  Julie A Schmittdiel; Marsha A Raebel; Wendy Dyer; Stanley Xu; Glenn K Goodrich; Emily B Schroeder; Jodi B Segal; Patrick J O' Connor; Gregory A Nichols; Jean M Lawrence; H Lester Kirchner; Andy J Karter; Jennifer Elston Lafata; Melissa G Butler; John F Steiner
Journal:  J Am Pharm Assoc (2003)       Date:  2014 Jul-Aug

4.  Choosing targets for glycaemia, blood pressure and low-density lipoprotein cholesterol in elderly individuals with diabetes mellitus.

Authors:  Susan R Kirsh; David C Aron
Journal:  Drugs Aging       Date:  2011-12-01       Impact factor: 3.923

5.  Do we need individualised prescribing quality assessment? The case of diabetes treatment.

Authors:  Petra Denig; Flora Haaijer-Ruskamp
Journal:  Int J Clin Pharm       Date:  2011-04

Review 6.  A Comprehensive Review of Drug-Drug Interactions with Metformin.

Authors:  Tore Bjerregaard Stage; Kim Brøsen; Mette Marie Hougaard Christensen
Journal:  Clin Pharmacokinet       Date:  2015-08       Impact factor: 6.447

7.  The impact of concordant and discordant comorbidities on patient-assessed quality of diabetes care.

Authors:  Eindra Aung; Maria Donald; Joseph Coll; Jo Dower; Gail M Williams; Suhail A R Doi
Journal:  Health Expect       Date:  2013-10-24       Impact factor: 3.377

Review 8.  Multiple chronic conditions and healthcare costs among adults.

Authors:  Usha Sambamoorthi; Xi Tan; Arijita Deb
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2015       Impact factor: 2.217

9.  Comparison of the cohort selection performance of Australian Medicines Terminology to Anatomical Therapeutic Chemical mappings.

Authors:  Guan N Guo; Jitendra Jonnagaddala; Sanjay Farshid; Vojtech Huser; Christian Reich; Siaw-Teng Liaw
Journal:  J Am Med Inform Assoc       Date:  2019-11-01       Impact factor: 4.497

10.  [Diabetes and osteoporosis: pathophysiological interactions and clinical importance for geriatric patients].

Authors:  M Lechleitner; K Pils; R Roller-Wirnsberger; E Beubler; R Gasser; P Mrak; F Hoppichler; P Pietschmann
Journal:  Z Gerontol Geriatr       Date:  2013-07       Impact factor: 1.281

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.